The TTF1+ xMD procured lung carcinoma cells demonstrated a 5-8-fold increase in KRAS mutation percentage in comparison to the whole cytospin macrodissection (46–76% vs. 9%). This evidence concerns the gene TTF1 and lung carcinoma.